In vitro metabolism of 8-2 fluorotelomer alcohol:: Interspecies comparisons and metabolic pathway refinement

被引:114
作者
Nabb, Diane L.
Szostek, Bogdan
Himmelstein, Matthew W.
Mawn, Michael P.
Gargas, Michael L.
Sweeney, Lisa M.
Stadler, Judith C.
Buck, Robert C.
Fasano, William J.
机构
[1] DuPont Haskell Lab Hlth & Environm Sci, Newark, DE 19714 USA
[2] Sapphire Grp Inc, Dayton, OH 45431 USA
关键词
8-2 fluorotelomer alcohol; glutathione conjugates; taurine conjugates; perfluorinated carboxylic acids; perfluorooctanoate; perfluorononanoic acid; fluorotelomer aldehydes; hepatocytes; hepatic clearance; microsomes; TELOMER-B ALCOHOL; TOXICOKINETIC MODEL; RATS; LIVER; MICE; HEPATOCYTES; HUMANS; BIOTRANSFORMATION; ELIMINATION; MICROSOMES;
D O I
10.1093/toxsci/kfm230
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The detection of perfluorinated organic compounds in the environment has generated interest in their biological fate. 8-2 Fluorotelomer alcohol (8-2 FTOH, C7F15CF2CH2CH2OH), a raw material used in the manufacture of fluorotelomer-based products, has been identified in the environment and has been implicated as a potential source for perfluorooctanoic acid (PFOA) in the environment. In this study, the in vitro metabolism of [3-C-14] 8-2 FTOH and selected acid metabolites by rat, mouse, trout, and human hepatocytes and by rat, mouse, and human liver microsomes and cytosol were investigated. Clearance rates of 8-2 FTOH in hepatocytes indicated rat > mouse > human >= trout. A number of metabolites not previously reported were identified, adding further understanding to the pathway for 8-2 FTOH metabolism. Neither perfluorooctanoate nor perfluorononanoate was detected from incubations with human microsomes. To further elucidate the steps in the metabolic pathway, hepatocytes were incubated with 8-2 fluorotelomer acid, 8-2 fluorotelomer unsaturated acid, 7-3 acid, 7-3 unsaturated acid, and 7-2 secondary fluorotelomer alcohol. Shorter chain perfluorinated acids were only observed in hepatocyte and microsome incubations of the 8-2 acids but not from the 7-3 acids. Overall, the results indicate that 8-2 FTOH is extensively metabolized in rats and mice and to a lesser extent in humans and trout. Metabolism of 8-2 FTOH to perfluorinated acids was extremely small and likely mediated by enzymes in the microsomal fraction. These results suggest that human exposure to 8-2 FTOH is not expected to be a significant source of PFOA or any other perfluorocarboxylic acids.
引用
收藏
页码:333 / 344
页数:12
相关论文
共 35 条
[1]  
Arias I.M., 1982, LIVER BIOL PATHOBIOL
[2]  
BAARNHIELM C, 1986, ACTA PHARMACOL TOX, V59, P113
[3]  
BAARNHIELM C, 1984, XENOBIOTICA, V14, P719
[4]   Metabolic inactivation of five glycidyl ethers in lung and liver of humans, rats and mice in vitro [J].
Boogaard, PJ ;
De Kloe, KP ;
Bierau, J ;
Kuiken, G ;
Borkulo, PED ;
Van Sittert, NJ .
XENOBIOTICA, 2000, 30 (05) :485-502
[5]   Physiological parameter values for physiologically based pharmacokinetic models [J].
Brown, RP ;
Delp, MD ;
Lindstedt, SL ;
Rhomberg, LR ;
Beliles, RP .
TOXICOLOGY AND INDUSTRIAL HEALTH, 1997, 13 (04) :407-484
[6]   EFFECTS OF 4-HYDROXYNONENAL ON ISOLATED HEPATOCYTES - STUDIES ON CHEMI-LUMINESCENCE RESPONSE, ALKANE PRODUCTION AND GLUTATHIONE STATUS [J].
CADENAS, E ;
MULLER, A ;
BRIGELIUS, R ;
ESTERBAUER, H ;
SIES, H .
BIOCHEMICAL JOURNAL, 1983, 214 (02) :479-487
[7]   Perfluorochemicals in pooled serum samples from United States residents in 2001 and 2002 [J].
Calafat, AM ;
Kuklenyik, Z ;
Caudill, SP ;
Reidy, JA ;
Needham, LL .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2006, 40 (07) :2128-2134
[8]   PHARMACOKINETIC CORRELATION BETWEEN INVITRO HEPATIC-MICROSOMAL ENZYME-KINETICS AND INVIVO METABOLISM OF IMIPRAMINE AND DESIPRAMINE IN RATS [J].
CHIBA, M ;
FUJITA, S ;
SUZUKI, T .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (04) :281-287
[9]   COMPARISON OF THE BIOTRANSFORMATION OF 1,3-BUTADIENE AND ITS METABOLITE, BUTADIENE MONOEPOXIDE, BY HEPATIC AND PULMONARY TISSUES FROM HUMANS, RATS AND MICE [J].
CSANADY, GA ;
GUENGERICH, FP ;
BOND, JA .
CARCINOGENESIS, 1992, 13 (07) :1143-1153
[10]  
Easterbrook J, 2001, DRUG METAB DISPOS, V29, P141